Cargando…

Special Issue “New Insights into Current and Future Vaccines against SARS-CoV-2 Variants of Concern and Interest”

Detalles Bibliográficos
Autores principales:	Qu, Bingqian, Li, Xue
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Editorial
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10056808/ https://www.ncbi.nlm.nih.gov/pubmed/36992187 http://dx.doi.org/10.3390/vaccines11030603

Ejemplares similares

The Emerging Concern and Interest SARS-CoV-2 Variants
por: Janik, Edyta, et al.
Publicado: (2021)

Understanding the Secret of SARS-CoV-2 Variants of Concern/Interest and Immune Escape
por: Lou, Fuxing, et al.
Publicado: (2021)

Special Issue “Advances in Antiviral Agents against SARS-CoV-2 and Its Variants”
por: Esposito, Francesca, et al.
Publicado: (2023)

SARS-CoV-2 Variants of Concern and Variants of Interest Receptor Binding Domain Mutations and Virus Infectivity
por: Liu, Haolin, et al.
Publicado: (2022)

Evolutionary insight into the emergence of SARS-CoV-2 variants of concern
Publicado: (2022)

Editorial: Revised World Health Organization (WHO) Terminology for Variants of Concern and Variants of Interest of SARS-CoV-2
por: Parums, Dinah V.
Publicado: (2021)

Description of a One-Year Succession of Variants of Interest and Concern of SARS-CoV-2 in Venezuela
por: Jaspe, Rossana C., et al.
Publicado: (2022)

Microarray Profiling of Vaccination-Induced Antibody Responses to SARS-CoV-2 Variants of Interest and Concern
por: Svetlova, Julia, et al.
Publicado: (2022)

Quantitative Mutation Analysis of Genes and Proteins of Major SARS-CoV-2 Variants of Concern and Interest
por: Liang, Fengyi
Publicado: (2023)

Predicting the mutational drivers of future SARS-CoV-2 variants of concern
por: Maher, M. Cyrus, et al.
Publicado: (2022)

Genome Sequences of SARS-CoV-2 P.1 (Variant of Concern) and P.2 (Variant of Interest) Identified in Uruguay
por: Panzera, Yanina, et al.
Publicado: (2021)

A Sanger-based approach for scaling up screening of SARS-CoV-2 variants of interest and concern
por: Bezerra, Matheus Filgueira, et al.
Publicado: (2021)

Molecular insights into the differential dynamics of SARS-CoV-2 variants of concern
por: Mandal, Nabanita, et al.
Publicado: (2022)

What is Currently Known About the SARS-CoV2 Variants of Concern
por: Souaid, Tarek, et al.
Publicado: (2021)

An issue of concern: unique truncated ORF8 protein variants of SARS-CoV-2
por: Hassan, Sk. Sarif, et al.
Publicado: (2022)

Prevalence of SARS-CoV-2 Variants of Concern and Variants of Interest in COVID-19 Breakthrough Infections in a Hospital in Monterrey, Mexico
por: Galán-Huerta, Kame A., et al.
Publicado: (2022)

Prediction of putative potential siRNAs for inhibiting SARS-CoV-2 strains, including variants of concern and interest
por: Saba, Abdullah Al, et al.
Publicado: (2022)

A Routine Sanger Sequencing Target Specific Mutation Assay for SARS-CoV-2 Variants of Concern and Interest
por: Lee, Sin Hang
Publicado: (2021)

COVID-19 and SARS-CoV-2 Variants: Current Challenges and Health Concern
por: Zeyaullah, Md., et al.
Publicado: (2021)

SARS-CoV-2 Variants of Concern
por: Choi, Jun Yong, et al.
Publicado: (2021)

Special Issue “Reproductive Health Concerns for Women”
por: Yang, Szu-Ting, et al.
Publicado: (2021)

Evaluation of the clinical and analytical performance of the Seegene allplex™ SARS-CoV-2 variants I assay for the detection of variants of concern (VOC) and variants of interests (VOI)
por: Caza, Mélissa, et al.
Publicado: (2021)

Special Issue: Fungal–Bacterial Interactions—Current Knowledge and Future Perspectives
por: Fidel, Paul L., et al.
Publicado: (2019)

Special Issue on “Disseminated Intravascular Coagulation: Current Understanding and Future Perspectives”
por: Yamakawa, Kazuma
Publicado: (2022)

Multivalent designed proteins protect against SARS-CoV-2 variants of concern
por: Hunt, Andrew C., et al.
Publicado: (2021)

Research progress on vaccine efficacy against SARS-CoV-2 variants of concern
por: Bian, Lianlian, et al.
Publicado: (2022)

Potency of Fusion-Inhibitory Lipopeptides against SARS-CoV-2 Variants of Concern
por: Schmitz, Katharina S., et al.
Publicado: (2022)

Neutralizing Efficacy of Encapsulin Nanoparticles against SARS-CoV2 Variants of Concern
por: Khaleeq, Sara, et al.
Publicado: (2023)

Development of Next Generation Vaccines against SARS-CoV-2 and Variants of Concern
por: Al-Fattah Yahaya, Abdul Aziz, et al.
Publicado: (2023)

Interest groups in US local politics: Introduction to the special issue
por: Anzia, Sarah F.
Publicado: (2022)

The emerging SARS-CoV-2 variants of concern
por: Sanyaolu, Adekunle, et al.
Publicado: (2021)

The origin of SARS-CoV-2 variants of concern
por: Burki, Talha
Publicado: (2022)

Ethical issues in psychiatry research: Special concerns for India
por: Rao, T. S. Sathyanarayana, et al.
Publicado: (2013)

Structures of SARS-CoV-2 B.1.351 neutralizing antibodies provide insights into cocktail design against concerning variants
por: Du, Shuo, et al.
Publicado: (2021)

The origins and potential future of SARS-CoV-2 variants of concern in the evolving COVID-19 pandemic
por: Otto, Sarah P., et al.
Publicado: (2021)

Special Issue: Advances in SARS-CoV-2 Infection
por: Contini, Carlo, et al.
Publicado: (2023)

Omicron variant: Current insights and future directions
por: Rana, Rashmi, et al.
Publicado: (2022)

A highly potent antibody effective against SARS-CoV-2 variants of concern
por: Fenwick, Craig, et al.
Publicado: (2021)

Correlates of Neutralization against SARS-CoV-2 Variants of Concern by Early Pandemic Sera
por: Vidal, Samuel J., et al.
Publicado: (2021)

A potent, broadly protective vaccine against SARS-CoV-2 variants of concern
por: Wang, Ziyan, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_turbkh9sljmvr61mtl1sh2uffh